Telix Pharmaceuticals Lim... (TLPPF)

PNK: TLPPF · Real-Time Price · USD

17.12

0.12 (0.70%)

At close: Apr 28, 2025, 1:24 PM

Telix Pharmaceuticals Income Statement

Financials in AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	783.21M	502.55M	160.1M	7.6M	5.21M	3.48M	195.14K	n/a	n/a
Cost of Revenue	273.53M	188.16M	130.76M	37.36M	22.09M	15.36M	n/a	3.79K	n/a
Gross Profit	509.68M	314.39M	29.34M	-29.77M	-16.88M	-11.88M	195.14K	-3.79K	n/a
Operating Income	82.13M	51.89M	-73.18M	-81.25M	-49.25M	-40.26M	-15.68M	-6.37M	-30K
Interest Income	10.86M	235K	1K	163K	67K	98K	332.75K	38.98K	14K
Pretax Income	56.06M	3.09M	-98.62M	-99.04M	-60.25M	-42.81M	-15.71M	-6.38M	-44K
Net Income	49.92M	5.21M	-104.08M	-80.51M	-44.89M	-27.87M	-13.83M	-6.38M	-44K
Selling & General & Admin	232.86M	134.16M	44.66M	17.35M	9.29M	7.22M	9.08M	2.67M	20K
Research & Development	194.64M	128.84M	57.86M	34.13M	23.09M	21.16M	18.69M	2.98M	10K
Other Expenses	54K	35.85M	3.09M	23.55M	2.96M	11.44M	11.63M	112.64K	n/a
Operating Expenses	427.55M	298.55M	102.52M	51.48M	32.38M	28.38M	27.85M	6.52M	30K
Interest Expense	36.49M	13.14M	406K	189K	1.18M	2.41M	29.02K	9.4K	n/a
Selling & Marketing Expenses	115.2M	54.87M	16.19M	5.89M	1.2M	312K	577.95K	213.76K	n/a
Cost & Expenses	701.08M	451.03M	233.28M	88.84M	54.47M	43.74M	27.85M	6.52M	30K
Income Tax Expense	6.14M	-2.12M	5.46M	-18.53M	-15.37M	-14.95M	-1.88M	9.4K	-14K
Shares Outstanding (Basic)	334.23M	323.66M	310.64M	282.21M	257.27M	233.44M	202.12M	127.99M	n/a
Shares Outstanding (Diluted)	350.75M	323.71M	310.64M	282.21M	257.27M	233.44M	202.12M	127.99M	n/a
EPS (Basic)	0.15	0.02	-0.34	-0.29	-0.17	-0.12	-0.07	-0.05	n/a
EPS (Diluted)	0.14	0.02	-0.34	-0.29	-0.17	-0.12	-0.07	-0.05	n/a
EBITDA	92.55M	22.97M	-92.84M	-70.07M	-44.94M	-36.17M	-25.82M	-6.77M	-14K
EBIT	92.55M	16.22M	-98.22M	-75.25M	-46.76M	-28.71M	-15.68M	-6.77M	n/a
Depreciation & Amortization	n/a	6.74M	5.38M	5.17M	4.88M	4.24M	6.93K	3.79K	30K